Mild to Moderate Alzheimer's Disease

1

Review clinical trials related to Mild to Moderate Alzheimer's Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease

This study is divided into two phases: a dose-escalation phase and an expansion cohort phase. The dose-escalation phase is a single-center study, while the expansion cohort phase is a multicenter, prospective, randomized, double-blind, placebo-controlled study.

Participants needed: 33
Trial details
Phase: Phase 1, Phase 2Age: 50+Biological sex: AllType: InterventionalSponsor: Xuanwu Hospital, BeijingUpdated: May 22, 2026Locations: 1
Eligibility criteria

Age ≥ 50 years, male or female. [+9]

Patients with a known allergic reaction to the investigational drug or similar d... [+15]